JCEM:女性钙摄入增加与死亡率风险降低有关

2013-06-09 JCEM dxy

钙和维生素D被推荐用于维持骨骼健康,但是他们的不利风险受到关注。一些临床研究暗示钙摄入可能有心脏保护作用,,然而,另外一些研究报道心血管风险增加与补充钙有关系。低和高血清25–羟维生素D水平都与死亡率的增加有关系。为了确定总钙和维生素D摄入与死亡率和来源异质性的关系,来自加拿大麦吉尔大学皇家维多利亚医院的David Goltzman教授及其团队进行了一项研究,该研究发现在女性,钙剂补充达到1000

钙和维生素D被推荐用于维持骨骼健康,但是他们的不利风险受到关注。一些临床研究暗示钙摄入可能有心脏保护作用,,然而,另外一些研究报道心血管风险增加与补充钙有关系。低和高血清25–羟维生素D水平都与死亡率的增加有关系。为了确定总钙和维生素D摄入与死亡率和来源异质性的关系,来自加拿大麦吉尔大学皇家维多利亚医院的David Goltzman教授及其团队进行了一项研究,该研究发现在女性,钙剂补充达到1000mg/d,以及膳食钙摄入增加可能与死亡率风险降低有关系。该研究结果在线发表在2013年5月23日的《临床内分泌代谢杂志》(The journal of clinical endocrinology & metabolism)上。

该研究是加拿大多中心骨质疏松研究队列,一项基于人群、10年随访(1995–2007)的纵向队列。随机选拔的社区居住的男性和女性。共有9033例钙和维生素D摄入数据和随访数据没有缺失的受试者接受研究。记录总钙摄入(乳制品、非乳制品食物,以及补充的钙)和总维生素D摄入(牛奶、奶酪和补充的维生素D)。主要评价指标是全因死亡率。

该研究结果表明,在10年随访期间,有1160例受试者死亡。仅在女性发现较高的总钙摄入可能有益,每日钙摄入每增加500mg的风险比为0.95(95%可信区间,0.89–1.01),并且没有发现来源异质性的证据;使用钙剂补充同样与死亡率的降低有关系,在那些钙剂量达到1000mg/d的受试者中仍有统计学意义的减少,使用者与未使用者相比,风险比为0.78(95%可信区间,0.66–0.92)。同时摄入维生素D,这些相关的水平没有改变。在男性之间,没有发现明确的关系。

该研究发现,钙剂补充达到1000mg/d,以及膳食钙摄入增加可能与死亡率风险降低有关系。没有发现维生素D摄入与死亡率利害关系的证据。

Calcium and Vitamin D Intake and Mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos).
Abstract
Context:Calcium and vitamin D are recommended for bone health, but there are concerns about adverse risks. Some clinical studies suggest that calcium intake may be cardioprotective, whereas others report increased risk associated with calcium supplements. Both low and high serum levels of 25-hydroxyvitamin D have been associated with increased mortality.Objective:The purpose of this study was to determine the association between total calcium and vitamin D intake and mortality and heterogeneity by source of intake.Design:The Canadian Multicentre Osteoporosis Study cohort is a population-based longitudinal cohort with a 10-year follow-up (1995-2007).Setting:This study included randomly selected community-dwelling men and women.Participants:A total of 9033 participants with nonmissing calcium and vitamin D intake data and follow-up were studied.Exposure:Total calcium intake (dairy, nondairy food, and supplements) and total vitamin D intake (milk, yogurt, and supplements) were recorded.Outcome:The outcome variable was all-cause mortality.Results:There were 1160 deaths during the 10-year period. For women only, we found a possible benefit of higher total calcium intake, with a hazard ratio of 0.95 (95% confidence interval, 0.89-1.01) per 500-mg increase in daily calcium intake and no evidence of heterogeneity by source; use of calcium supplements was also associated with reduced mortality, with hazard ratio of 0.78 (95% confidence interval, 0.66-0.92) for users vs nonusers with statistically significant reductions remaining among those with doses up to 1000 mg/d. These associations were not modified by levels of concurrent vitamin D intake. No definitive associations were found among men.Conclusions:Calcium supplements, up to 1000 mg/d, and increased dietary intake of calcium may be associated with reduced risk of mortality in women. We found no evidence of mortality benefit or harm associated with vitamin D intake.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2062805, encodeId=2e4a2062805da, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Jun 12 20:13:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820625, encodeId=6edb18206255a, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Sat Feb 15 03:13:00 CST 2014, time=2014-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777426, encodeId=84b21e77426bf, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Apr 21 16:13:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5798, encodeId=2fd25e9809, content=wurwznyawidq, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=readqotfyrah, createdTime=Fri Jun 21 22:22:00 CST 2013, time=2013-06-21, status=1, ipAttribution=)]
    2013-06-12 achengzhao
  2. [GetPortalCommentsPageByObjectIdResponse(id=2062805, encodeId=2e4a2062805da, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Jun 12 20:13:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820625, encodeId=6edb18206255a, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Sat Feb 15 03:13:00 CST 2014, time=2014-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777426, encodeId=84b21e77426bf, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Apr 21 16:13:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5798, encodeId=2fd25e9809, content=wurwznyawidq, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=readqotfyrah, createdTime=Fri Jun 21 22:22:00 CST 2013, time=2013-06-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2062805, encodeId=2e4a2062805da, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Jun 12 20:13:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820625, encodeId=6edb18206255a, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Sat Feb 15 03:13:00 CST 2014, time=2014-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777426, encodeId=84b21e77426bf, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Apr 21 16:13:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5798, encodeId=2fd25e9809, content=wurwznyawidq, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=readqotfyrah, createdTime=Fri Jun 21 22:22:00 CST 2013, time=2013-06-21, status=1, ipAttribution=)]
    2014-04-21 smallant2015
  4. [GetPortalCommentsPageByObjectIdResponse(id=2062805, encodeId=2e4a2062805da, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Jun 12 20:13:00 CST 2013, time=2013-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820625, encodeId=6edb18206255a, content=<a href='/topic/show?id=0c6a1009105e' target=_blank style='color:#2F92EE;'>#风险降低#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100910, encryptionId=0c6a1009105e, topicName=风险降低)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd18451, createdName=xre2008, createdTime=Sat Feb 15 03:13:00 CST 2014, time=2014-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777426, encodeId=84b21e77426bf, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Mon Apr 21 16:13:00 CST 2014, time=2014-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5798, encodeId=2fd25e9809, content=wurwznyawidq, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=readqotfyrah, createdTime=Fri Jun 21 22:22:00 CST 2013, time=2013-06-21, status=1, ipAttribution=)]
    2013-06-21 readqotfyrah

    wurwznyawidq

    0

相关资讯

BMJ:钙或可预防甲状旁腺功能亢进

  一项首次前瞻性评估甲状旁腺功能亢进与钙摄入量之间关联的研究数据分析显示,女性钙摄入量增加与原发性甲状旁腺功能亢进风险降低有关。   这项研究是由布里格姆妇女医院的Julie M. Paik博士及其同事进行,他们对护士健康研究Ⅰ中的58,354名女性进行了分析。护士健康研究Ⅰ是从1976年开始的一项前瞻性队列研究,受试者均每2年填写1次调查问卷。研究者采用饮食频次量表了解受试者的膳食摄入情况,

Cancer:高钙摄入可降低大肠癌癌前病变的风险

  在华盛顿召开的美国癌症学肿瘤会年会上,研究人员发表了一项最新的研究成果:高钙摄入可降低某些大肠癌癌前病变的风险,但其只与特定基因相关。相关研究成果发表在4月10的《癌症》杂志上。   高钙摄入可降低由两个基因(KCNJ1和SLC12A1)突变诱导的大肠癌癌前病变和直肠病变的风险,但不降低没有基因突变的人。研究人员说,这项发现可能有助于解释先前研究的关于钙的摄入量与结直肠腺瘤病变结果不一致的原

Am J Clin Nutr:钙摄入和个体冠状动脉钙化并无关联

近日,来自哈佛医学院的研究者通过研究揭示了,钙摄入和冠状动脉钙化并不关系,这就告知那些以补充钙质来增加骨质健康的成人,并不用担心自身血管钙化的问题。相关研究成果于11月7日刊登于国际杂志American Journal of Clinical Nutrition上。 冠状动脉钙化得分可以表现出心脏中钙化斑堵塞动脉的严重程度,同时也是心脏病发作的毒力指示器。研究者Elizabeth (Lisa)

JCEM:维生素D与钙减少老年人死亡率

近日,一项研究证实维生素D和钙同时使用可降低死亡率,但单用维生素D却不会带来此种功效。 这项刊登在在Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM)杂志上的一项研究表明:当摄入维生素D时,同时服用钙可以降低老年人死亡率,因此该项研究提出了一个可能延长寿命的手段。 在过去十年中,已经有越来越多研